Lexeo Therapeutics (NASDAQ:LXEO) Given “Buy” Rating at HC Wainwright
HC Wainwright restated their buy rating on shares of Lexeo Therapeutics (NASDAQ:LXEO – Free Report) in a research report released on Wednesday morning,Benzinga reports. They currently have a $23.00 target price on the stock. A number of other equities research analysts have also commented on LXEO. Leerink Partners decreased their price objective on Lexeo Therapeutics […]
HC Wainwright restated their buy rating on shares of Lexeo Therapeutics (NASDAQ:LXEO – Free Report) in a research report released on Wednesday morning,Benzinga reports. They currently have a $23.00 target price on the stock. A number of other equities research analysts have also commented on LXEO. Leerink Partners decreased their price objective on Lexeo Therapeutics […]
